Viewing Study NCT06723457


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2026-01-04 @ 10:31 PM
Study NCT ID: NCT06723457
Status: RECRUITING
Last Update Posted: 2025-08-13
First Post: 2024-12-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
Sponsor: Northwestern University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module